The Cannabist Company Holdings Inc.
CBST.NENEOHealthcare● Active
$0.04
+$0.00(+0.00%)
Market Cap$17471256
P/E Ratio—
52W High$0.225
52W Low$0.03
The Cannabist Company Holdings Inc. (CBST.NE) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CBST.NE · earnings · updated Jun 8, 2026
Latest Earnings
Q4 FY2025Report Date: Nov 10, 2025EPS Actual
-$0.04
Est. -$0.06 · +33.0%
Revenue
$0.11B
Est. $0.08B · +39.5%
Fiscal Period
Q4 FY2025
FY ends December
Report Date
Nov 10, 2025
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
CBST.NE reports quarterly as a NEO-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | May 27, 2026 | -$0.06 | — | — | — | $0.12B | — |
| ◌ Q2 FY2026 | May 18, 2026 | -$0.06 | — | — | — | $0.12B | — |
| ▲ Q4 FY2025 | Nov 10, 2025 | -$0.06 | -$0.04 | +33.0% | $0.11B | $0.08B | +39.5% |
| ▼ Q3 FY2025 | Aug 7, 2025 | -$0.03 | -$0.22 | -654.9% | $0.12B | $0.08B | +50.1% |
| ▼ Q2 FY2025 | May 7, 2025 | -$0.04 | -$0.07 | -75.0% | $0.12B | $0.09B | +39.6% |
| ▼ Q1 FY2025 | Mar 11, 2025 | -$0.04 | -$0.34 | -750.0% | $0.14B | $0.09B | +55.0% |
| ▼ Q4 FY2024 | Nov 7, 2024 | -$0.00 | -$0.01 | -100.0% | $0.16B | $0.11B | +42.5% |
| ▲ Q3 FY2024 | Aug 8, 2024 | -$0.05 | -$0.03 | +40.0% | $0.17B | $0.18B | -3.5% |
Q2 FY2026
May 27, 2026
EPS Actual
—
EPS Est.
-$0.06
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 18, 2026
EPS Actual
—
EPS Est.
-$0.06
EPS Surpr.
—
Revenue
—
Q4 FY2025
Nov 10, 2025Beat
EPS Actual
-$0.04
EPS Est.
-$0.06
EPS Surpr.
+33.0%
Revenue
$0.11B
Q3 FY2025
Aug 7, 2025Miss
EPS Actual
-$0.22
EPS Est.
-$0.03
EPS Surpr.
-654.9%
Revenue
$0.12B
Q2 FY2025
May 7, 2025Miss
EPS Actual
-$0.07
EPS Est.
-$0.04
EPS Surpr.
-75.0%
Revenue
$0.12B
Q1 FY2025
Mar 11, 2025Miss
EPS Actual
-$0.34
EPS Est.
-$0.04
EPS Surpr.
-750.0%
Revenue
$0.14B
Q4 FY2024
Nov 7, 2024Miss
EPS Actual
-$0.01
EPS Est.
-$0.00
EPS Surpr.
-100.0%
Revenue
$0.16B
Q3 FY2024
Aug 8, 2024Beat
EPS Actual
-$0.03
EPS Est.
-$0.05
EPS Surpr.
+40.0%
Revenue
$0.17B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Q3 FY2026 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Q2 FY2026 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Q1 FY2026 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Q4 FY2025 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Q3 FY2025 | $-0.04 | $-0.04 | $-0.04 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q2 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q1 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2025 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2025 | $0.1B | $0.1B | $0.1B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q4 FY2025 | Nov 10, 2025 | +33.0% | $0.09 | $0.10 | +17.65% |
| ▼ Q3 FY2025 | Aug 7, 2025 | -654.9% | $0.13 | $0.14 | +3.85% |
| ▼ Q2 FY2025 | May 7, 2025 | -75.0% | $0.11 | $0.10 | -4.76% |
| ▼ Q1 FY2025 | Mar 11, 2025 | -750.0% | $0.08 | $0.07 | -6.67% |
| ▼ Q4 FY2024 | Nov 7, 2024 | -100.0% | $0.20 | $0.20 | -2.50% |
| ▲ Q3 FY2024 | Aug 8, 2024 | +40.0% | $0.32 | $0.34 | +7.94% |
| ▼ Q2 FY2024 | May 9, 2024 | -60.0% | $0.43 | $0.41 | -3.53% |
| ▼ Q1 FY2024 | Mar 13, 2024 | -200.0% | $0.34 | $0.31 | -10.29% |
Q4 FY2025+17.65%
Report Date
Nov 10, 2025
EPS Beat/Miss
+33.0%
Price Before
$0.09
Price After
$0.10
Q3 FY2025+3.85%
Report Date
Aug 7, 2025
EPS Beat/Miss
-654.9%
Price Before
$0.13
Price After
$0.14
Q2 FY2025-4.76%
Report Date
May 7, 2025
EPS Beat/Miss
-75.0%
Price Before
$0.11
Price After
$0.10
Q1 FY2025-6.67%
Report Date
Mar 11, 2025
EPS Beat/Miss
-750.0%
Price Before
$0.08
Price After
$0.07
Q4 FY2024-2.50%
Report Date
Nov 7, 2024
EPS Beat/Miss
-100.0%
Price Before
$0.20
Price After
$0.20
Q3 FY2024+7.94%
Report Date
Aug 8, 2024
EPS Beat/Miss
+40.0%
Price Before
$0.32
Price After
$0.34
Q2 FY2024-3.53%
Report Date
May 9, 2024
EPS Beat/Miss
-60.0%
Price Before
$0.43
Price After
$0.41
Q1 FY2024-10.29%
Report Date
Mar 13, 2024
EPS Beat/Miss
-200.0%
Price Before
$0.34
Price After
$0.31
Avg Beat Reaction+12.79%
Avg Miss Reaction-3.98%
Beat Rate2 / 8 quarters
Largest Move+17.65% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CBST.NE ends December
The Cannabist Company Holdings Inc. (CBST.NE) most recently reported earnings on November 10, 2025 for Q4 FY2025, posting EPS of $-0.04 — beating the analyst consensus of $-0.06 by +33.0%. The next CBST.NE earnings date is expected around September 1, 2026.
Each quarter, investors track CBST.NE earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CBST.NE revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CBST.NE's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CBST.NE earnings · 5 questionsThe Cannabist Company Holdings Inc.'s next earnings report is expected around September 1, 2026. CBST.NE typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CBST.NE historically reports after market close (AMC).
CBST.NE earnings datewhen is CBST.NE earningsCBST.NE next earnings datewhen does CBST.NE report earningsCBST.NE earnings calendar
▸ Source: FMP · The Cannabist Company Holdings Inc. SEC filings · US GAAP · The Cannabist Company Holdings Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026